Cancer Vaccines

Cancer vaccines focus on both therapeutic and preventive approaches to stimulate the immune system against tumor cells. These vaccines target specific tumor-associated antigens to enhance immune recognition and destruction of cancer cells. Research in this track includes peptide-based vaccines, dendritic cell vaccines, and nucleic acid–based platforms designed to induce strong, durable anti-tumor responses. Emphasis is placed on improving vaccine efficacy, personalizing treatments, and combining vaccines with other immunotherapies such as checkpoint inhibitors. Advances in understanding tumor immunology and immune evasion mechanisms are driving the development of safer, more effective cancer vaccines that aim to prevent tumor growth and improve patient outcomes.

    Related Conference of Cancer Vaccines

    March 12-13, 2026

    8th International Conference on Digital Health

    London, UK
    April 08-09, 2026

    5th International Congress on Global Healthcare

    Vienna, Austria
    April 20-21, 2026

    7th Global Summit on Digital Therapeutics

    Barcelona, Spain
    April 27-28, 2026

    8th World Summit on Women's Health and Cancer Awareness

    Vancouver, Canada
    June 01-02, 2026

    2nd International Congress on Primary Health and Safety

    Zurich, Switzerland
    June 15-16, 2026

    8th World Conference on Vaccine and Immunology

    Paris, France
    July 13-14, 2026

    13th World congress on Hospice and Palliative care

    Amsterdam, Netherlands
    July 23-24, 2026

    37th European Heart and Heart Failure Congress

    Paris, France
    August 27-28, 2026

    22nd Global Biomarkers and Clinical Research Summit

    Paris, France
    October 19-20, 2026

    6th Euro-Global Summit on Probiotics & Nutraceuticals

    Paris, France
    December 16-17, 2026

    7th Global Summit on Public Health

    Amsterdam, Netherlands

    Cancer Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in